In OGDM‐Insulin, faster changes in weight z‐score could have important clinical implications if those persist after 60 months of age and translate into higher overweight and obesity risk later in childhood.9 This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.